Serveur d'exploration COVID et hydrochloroquine - Corpus (Accueil)

Index « MedMesh.i » - entrée « Dexamethasone »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Developing Countries < Dexamethasone < Diabetes Complications  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 29.
[0-20] [0 - 20][0 - 29][20-28][20-40]
Ident.Authors (with country if any)Title
000027 (2021) Helen PearsonHow COVID broke the evidence pipeline.
000086 (2021) Irina Panovska-Stavridis ; Nevenka Ridova ; Tatjana Stojanoska ; Ilir Demiri ; Milena Stevanovic ; Simona Stojanovska ; Tara Ristevska ; Aleksandar Dimkovski ; Venko Filipce ; Aleksandar Dimovski ; Aleksandra GrozdanovaInsight in the Current Progress in the Largest Clinical Trials for Covid-19 Drug Management (As of January 2021).
000152 (2021) Mohamed A. Taha ; Christian A. Hall ; Colin J. Shortess ; Richard F. Rathbone ; Henry P. BarhamTreatment Protocol for COVID-19 Based on T2R Phenotype.
000189 (2021) Nicholas J. White ; Nathalie Strub-Wourgaft ; Abul Faiz ; Philippe J. GuerinGuidelines should not pool evidence from uncomplicated and severe COVID-19.
000194 (2021) Waqas Aslam ; Carla R. Lamb ; Nadia AliTorsades de pointes in SARS-CoV-2 (COVID-19) pneumonia: medicine reconciliation and careful monitoring of QTc interval may help prevent cardiac complications.
000218 (2021) Jacobo Rogado ; Pedro Gull N ; Berta Obispo ; Gloria Serrano ; Miguel LaraProlonged SARS-CoV-2 viral shedding in patients with solid tumours and associated factors.
000243 (2021) Chris R. Triggle ; Devendra Bansal ; Hong Ding ; Md Mazharul Islam ; Elmoubashar Abu Baker Abd Farag ; Hamad Abdel Hadi ; Ali A. SultanA Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic.
000368 (2021) Waleed Alhazzani ; Laura Evans ; Fayez Alshamsi ; Morten Hylander M Ller ; Marlies Ostermann ; Hallie C. Prescott ; Yaseen M. Arabi ; Mark Loeb ; Michelle Ng Gong ; Eddy Fan ; Simon Oczkowski ; Mitchell M. Levy ; Lennie Derde ; Amy Dzierba ; Bin Du ; Flavia Machado ; Hannah Wunsch ; Mark Crowther ; Maurizio Cecconi ; Younsuck Koh ; Lisa Burry ; Daniel S. Chertow ; Wojciech Szczeklik ; Emilie Belley-Cote ; Massimiliano Greco ; Malgorzata Bala ; Ryan Zarychanski ; Jozef Kesecioglu ; Allison Mcgeer ; Leonard Mermel ; Manoj J. Mammen ; Sheila Nainan Myatra ; Amy Arrington ; Ruth Kleinpell ; Giuseppe Citerio ; Kimberley Lewis ; Elizabeth Bridges ; Ziad A. Memish ; Naomi Hammond ; Frederick G. Hayden ; Muhammed Alshahrani ; Zainab Al Duhailib ; Greg S. Martin ; Lewis J. Kaplan ; Craig M. Coopersmith ; Massimo Antonelli ; Andrew RhodesSurviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update.
000391 (2021) Kanupriya Arora ; Prasan Kumar PandaSteroid harms if given early in COVID-19 viraemia.
000473 (2020) Catherine Knowlson ; David J. TorgersonEffects of rapid recruitment and dissemination on Covid-19 mortality: the RECOVERY trial.
000502 (2021) Carrie PrintzResearch shows racial disparity, mortality data for patients with cancer and COVID-19.
000510 (2021) Muhammad Sani Ismaila ; Faruku Bande ; Aminu Ishaka ; Aminatu Abubakar Sani ; Karla GeorgesTherapeutic options for COVID-19: a quick review.
000642 (2020) N. Trivedi ; A. Verma ; D. KumarPossible treatment and strategies for COVID-19: review and assessment.
000643 (2021) Fiona Marra ; Elise J. Smolders ; Omar El-Sherif ; Alison Boyle ; Katherine Davidson ; Andrew J. Sommerville ; Catia Marzolini ; Marco Siccardi ; David Burger ; Sara Gibbons ; Saye Khoo ; David BackRecommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment.
000654 (2021) James H. Mcmahon ; Michael J. Lydeamore ; Andrew J. StewardsonBringing evidence from press release to the clinic in the era of COVID-19.
000686 (2020) Hilary Miller-Handley ; Keith Luckett ; Amit GovilTreatment Options for Coronavirus Disease 2019 in Patients With Reduced or Absent Kidney Function.
000733 (2021) Imad NaasaniCOMPARE Analysis, a Bioinformatic Approach to Accelerate Drug Repurposing against Covid-19 and Other Emerging Epidemics.
000801 (2020) Eugene Mamontov ; Yongqiang Cheng ; Luke L. Daemen ; Alexander I. Kolesnikov ; Anibal J. Ramirez-Cuesta ; Matthew R. Ryder ; Matthew B. StoneHydration-Induced Disorder Lowers the Energy Barriers for Methyl Rotation in Drug Molecules.
000886 (2020) Elizabeth Delorme-Axford ; Daniel J. KlionskyHighlights in the fight against COVID-19: does autophagy play a role in SARS-CoV-2 infection?
000A19 (2020) Fabrizio Cantini ; Delia Goletti ; Linda Petrone ; Saied Najafi Fard ; Laura Niccoli ; Rosario FotiImmune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review.
000A65 (2020) Amanda Baroutjian ; Carol Sanchez ; Dessy Boneva ; Mark Mckenney ; Adel ElkbuliSARS-CoV-2 pharmacologic therapies and their safety/effectiveness according to level of evidence.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/MedMesh.i -k "Dexamethasone" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/MedMesh.i  \
                -Sk "Dexamethasone" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Dexamethasone
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021